Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study

Objective: To compare the efficacy and safety of the novel SVILE regimen with the P-GemOx regimen in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type (ND-ENKTL). Methods: From April 2015 to July 2018, 103 patients with ND-ENKTL were randomly assigned to SVILE (expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Liqiang, Yang, Lei, Ye, Jin, Cong, Jia, Li, Xin, Yao, Na, Yang, Jing, Cui, Xueying, Ding, Jing, Wu, Yiping, Wang, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476087/
https://www.ncbi.nlm.nih.gov/pubmed/32944407
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476087/
https://www.ncbi.nlm.nih.gov/pubmed/32944407
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0160

Ejemplares similares